Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-23T04:41:51.907Z Has data issue: false hasContentIssue false
  • English
  • Français

The use of tranexamic acid for trauma patients?

Published online by Cambridge University Press:  11 May 2015

Bryan J. Weber  and
Colleen B. Kjelland
Bryan J. Weber*
Affiliation:
Department of Emergency Medicine, University of Alberta, Edmonton, AB
Colleen B. Kjelland
Affiliation:
Department of Emergency Medicine, University of Alberta, Edmonton, AB
*
Walter C. MacKenzie Health Sciences Centre, 1G1.59, 8440-112 Street, Edmonton, AB T6G 2B7; [email protected]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

CRASH-2tranexamic acidtrauma
Type
Knowledge to Practice • Des connaissances à la pratique
Information
Canadian Journal of Emergency Medicine , Volume 14 , Issue 1 , January 2012 , pp. 53 - 56
Copyright
Copyright © Canadian Association of Emergency Physicians 2012

References

REFERENCES

1.Krug, EG, Sharma, GK, Lozano, R. The global burden of injuries. Am J Public Health 2000;90:523–6, doi:10.2105/AJPH.90.4.523.Google ScholarPubMed
2.Sauaia, A, Moore, F, Moore, E, et al. Epidemiology of trauma deaths: a reassessment. J Trauma 1995;38:185–93, doi:10.1097/00005373-199502000-00006.CrossRefGoogle ScholarPubMed
3.Heckbert, S, Vedder, N, Hoffman, W, et al. Outcome after hemorrhagic shock in trauma patients. J Trauma 1998;45:545–9, doi:10.1097/00005373-199809000-00022.CrossRefGoogle ScholarPubMed
4.Hoylaerts, M, Lijnen, H, Collen, D. Studies on the mechanism of the antifibrinolytic action of tranexamic acid. Biochim Biophys Acta 1981;673:75–85, doi:10.1016/0304-4165(81)90312-3.CrossRefGoogle ScholarPubMed
5.Henry, DA, Carless, PA, Moxey, AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007;(4):D001886.CrossRefGoogle ScholarPubMed
6.Horrow, J, Hlavacek, J, Strong, M, et al. Prophylactic tranexamic acid decreases bleeding after cardiac operations. J Thorac Cardiovasc Surg 1990;99:70–4.CrossRefGoogle ScholarPubMed
7.Horrow, JC, Riper, DFV, Strong, MD, et al. Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation 1991;84:2063–70.CrossRefGoogle ScholarPubMed
8.Boylan, JF, Klinck, JR, Sandler, AN, et al. Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology 1996;85:1043–8; discussion 30A-31A.CrossRefGoogle ScholarPubMed
9.Benoni, G, Fredin, H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br 1996;78:434–40.CrossRefGoogle ScholarPubMed
10.Hiippala, ST, Strid, LJ, Wennerstrand, MI, et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 1997;84:839–44.CrossRefGoogle ScholarPubMed
11.Ekbäck, G, Axelsson, K, Ryttberg, L, et al. Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg 2000;91:1124–30, doi:10.1213/00000539-200011000-00014.CrossRefGoogle ScholarPubMed
12.Zufferey, PJ, Miquet, M, Quenet, S, et al. Tranexamic acid in hip fracture surgery: a randomized controlled trial. Br J Anaesth 2010;104:23–30, doi:10.1093/bja/aep314.CrossRefGoogle ScholarPubMed
13.Lawson, J, Murphy, M. Challenges for providing effective hemostasis in surgery and trauma. Semin Hematol 2004;41(1 Suppl 1):55–64.CrossRefGoogle ScholarPubMed
14.Coats, T, Roberts, I, Shakur, H. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev 2004;(4):D004896.CrossRefGoogle ScholarPubMed
15.Spahn, DR, Cerny, V, Coats, TJ, et al. Task Force for Advanced Bleeding Care in Trauma. Management of bleeding following major trauma: a European guideline. Crit Care 2007;11:R17, doi:10.1186/cc5686.CrossRefGoogle ScholarPubMed
16.Martin, K, Wiesner, G, Breuer, T, et al. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients. Anesth Analg 2008;107:1783–90.CrossRefGoogle ScholarPubMed
17.Murkin, JM, Falter, F, Granton, J, et al. High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 2010;110:350–3, doi:10.1213/ANE.0b013e3181c92b23.CrossRefGoogle ScholarPubMed
18.Levy, JH. Antifibrinolytic therapy: new data and new concepts. Lancet 2010;376:3–4, doi:10.1016/S0140-6736(10)60939-7.CrossRefGoogle ScholarPubMed
19.Furtmüller, R, Schlag, M, Berger, M, et al. Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid(A) receptor antagonistic effect. J Pharmacol Exp Ther 2002;301:168–73, doi:10.1124/jpet.301.1.168.CrossRefGoogle ScholarPubMed